Peptidomimetics

Group of reference and pioneering in Spain in peptidomimetics. Our research requires coordinated use of molecular modeling, synthetic methodologies in solution and solid-phase (peptides/small molecules) and biological evaluation. Experience in enzymatic inhibitors, mimetics of analgesic and antitumor peptides, and of neuropeptides. Focused currently in the modulation of protein-protein modulators of therapeutic interest and of different ion channels and associated proteins (for new analgesic and cardiovascular). Constants of the group: the collaboration with other groups, pharmaceutical companies (Antibióticos, NovoNordisk, PharmaMar, Givaudan, Alodia, Mediczen), and the multidisciplinary training of young researchers. Participation in the COST action BM1301 and the Fundación General CSIC’s ComFuturo program supported by the Marie Skłodowska-Curie grant agreement 101034263.